Tang Kevin C
- SEC CIK
- 0001178579
In the past year, 10 open-market purchase filings worth $28.1M and 1 sale filing worth $54.4K.
Current role at each company
- BOLD Boundless Bio, Inc.10% Owneras of Aug 28, 2026
- FULC Fulcrum Therapeutics, Inc.10% Owneras of Jul 20, 2026
- AUPH Aurinia Pharmaceuticals Inc.Chief Executive Officeras of Jun 2, 2026
- OMIC Singular Genomics Systems, Inc.10% Owneras of Feb 27, 2025
- TCRR TCR2 Therapeutics Inc.10% Owneras of Feb 14, 2024
Show 5 more companies
- Rain Oncology Inc.10% Owneras of Feb 2, 2024
- JNCE Jounce Therapeutics, Inc.Director, 10% Owneras of May 5, 2023
- LJPC La Jolla Pharmaceutical CoDirector, 10% Owneras of Aug 24, 2022
- APVO Aptevo Therapeutics Inc.Other: Exit Filingas of Nov 26, 2021
- ODT Odonate Therapeutics, Inc.Chief Executive Officeras of Nov 19, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $28.1M
- 10 filings
- Sold
- $54.4K
- 1 filing
- Net
- +$28.1M
- Bought minus sold
- Companies
- 3
- With open-market trades
Trades
Every Form 4 that lists Tang Kevin C as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
BOLD Boundless Bio, Inc.
10% Owner7 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 28, 2026 (view filing)4:16 PM ET | Aug 26 | 2 days | Tang Kevin C and 1 other10% Owner | SSale | −18.3K | $2.97 | −$54.4K | −0.6%2.84M after | |
| Jul 21, 2026 (view filing)7:38 PM ET | Jul 17-21 | 4 days | Tang Kevin C and 1 other10% Owner | PPurchase | +4.86K | $2.44 | +$11.9K | +0.2%2.86M after | 3 lots |
| Jul 16, 2026 (view filing)8:10 PM ET | Jul 14-16 | 2 days | Tang Kevin C and 1 other10% Owner | PPurchase | +64.0K | $2.43 | +$155.6K | +2.3%2.85M after | 3 lots |
| Jul 13, 2026 (view filing)7:06 PM ET | Jul 9-13 | 4 days | Tang Kevin C and 1 other10% Owner | PPurchase | +91.6K | $2.42 | +$222.1K | +3.4%2.79M after | 3 lots |
| Jul 8, 2026 (view filing)8:06 PM ET | Jul 6-8 | 2 days | Tang Kevin C and 1 other10% Owner | PPurchase | +57.2K | $2.48 | +$141.9K | +2.2%2.70M after | 3 lots |
| Jul 2, 2026 (view filing)7:45 PM ET | Jun 30-Jul 2 | 2 days | Tang Kevin C and 1 other10% Owner | PPurchase | +107.5K | $2.50 | +$268.9K | +4.2%2.64M after | 4 lots |
| Jun 29, 2026 (view filing)7:56 PM ET | Jun 25-29 | 4 days | Tang Kevin C and 1 other10% Owner | PPurchase | +286.3K | $2.50 | +$714.8K | +12.7%2.53M after | 6 lots |
FULC Fulcrum Therapeutics, Inc.
10% Owner2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 20, 2026 (view filing)9:10 PM ET | Jul 16-17 | 4 days | Tang Kevin C and 1 other10% Owner | PPurchase | +167.6K | $3.55 | +$594.7K | +2.4%7.08M after | 2 lots |
| Jul 15, 2026 (view filing)7:50 PM ET | Jul 13-15 | 2 days | Tang Kevin C and 1 other10% Owner | PPurchase | +249.9K | $3.57 | +$891.1K | +3.8%6.91M after | 4 lots |
AUPH Aurinia Pharmaceuticals Inc.
Chief Executive Officer5 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 2, 2026 (view filing)9:54 PM ET | May 29-Jun 2 | 4 days | Tang Kevin C and 1 otherChief Executive Officer | PPurchase | +814.6K | $15.29 | +$12.5M | +6.7%13.0M after | 5 lots |
| Mar 3, 2026 (view filing) | Feb 27-Mar 3 | 4 days | Tang Kevin CDirector | PPurchase | +900.0K | $14.10 | +$12.7M | +7.9%12.2M after | 6 lots |
| Aug 5, 2025 (view filing) | Aug 1-5 | 4 days | Tang Kevin CDirector | PPurchase | +1.30M | $10.45 | +$13.6M | +13.0%11.3M after | 3 lots |
| Mar 4, 2025 (view filing) | Feb 28-Mar 4 | 4 days | Tang Kevin CDirector | PPurchase | +1.60M | $7.95 | +$12.7M | +19.0%10.0M after | 6 lots |
| Dec 9, 2024 (view filing) | Dec 5-9 | 4 days | Tang Kevin CDirector | PPurchase | +1.20M | $9.02 | +$10.8M | +16.6%8.43M after | 3 lots |
OMIC Singular Genomics Systems, Inc.
10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 18, 2024 (view filing)4:31 PM ET | Sep 16-18 | 2 days | Tang Kevin C and 2 others10% Owner | PPurchase | +122.4K | $14.75 | +$1.81M | +49.0%372.0K after | 3 lots |
Rain Oncology Inc.
10% Owner3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 18, 2023 (view filing)6:29 PM ET | Dec 14-18 | 4 days | Tang Kevin C and 2 others10% Owner | SSale | −174.0K | $1.20 | −$209.4K | −4.3%3.85M after | 3 lots |
| Oct 13, 2023 (view filing)4:57 PM ET | Oct 11-13 | 2 days | Tang Kevin C and 2 others10% Owner | PPurchase | +284.1K | $0.982 | +$279.0K | +7.6%4.02M after | 5 lots |
| Jun 1, 2023 (view filing)6:46 PM ET | May 30-Jun 1 | 2 days | Tang Kevin C and 2 others10% Owner | PPurchase | +1.09M | $1.06 | +$1.16M | +41.0%3.74M after | 9 lots |
TCRR TCR2 Therapeutics Inc.
10% Owner4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 30, 2023 (view filing)8:02 PM ET | May 25 | 5 days | Tang Kevin C and 2 others10% Owner | PPurchase | +50.0K | $1.72 | +$86.0K | +1.2%4.39M after | |
| May 15, 2023 (view filing)5:12 PM ET | May 11-12 | 4 days | Tang Kevin C and 2 others10% Owner | PPurchase | +44.9K | $1.95 | +$87.6K | +1.0%4.34M after | 2 lots |
| May 10, 2023 (view filing)7:02 PM ET | May 8-10 | 2 days | Tang Kevin C and 2 others10% Owner | PPurchase | +84.0K | $1.95 | +$163.8K | +2.0%4.30M after | 3 lots |
| May 5, 2023 (view filing)6:52 PM ET | May 3-5 | 2 days | Tang Kevin C and 2 others10% Owner | PPurchase | +289.6K | $1.89 | +$547.9K | +7.4%4.22M after | 4 lots |
JNCE Jounce Therapeutics, Inc.
Director, 10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 14, 2023 (view filing)8:39 PM ET | Mar 13-14 | 1 day | Tang Kevin C and 2 others10% Owner | PPurchase | +86.0K | $0.9997 | +$86.0K | +1.6%5.30M after | 2 lots |
LJPC La Jolla Pharmaceutical Co
Director, 10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 1, 2021 (view filing)7:07 PM ET | Nov 29-Dec 1 | 2 days | Tang Kevin C and 3 othersDirector, 10% Owner | SSale | −441.3K | $3.93 | −$1.73M | −4.4%9.61M after | 5 lots |
APVO Aptevo Therapeutics Inc.
Other: Exit Filing2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 26, 2021 (view filing)1:02 PM ET | Nov 23 | 3 days | Tang Kevin C and 2 othersOther: Exit Filing | SSale | −921.3K | $11.25 | −$10.4M | −100.0%0 after | 7 lots |
| Nov 22, 2021 (view filing)5:26 PM ET | Nov 18-22 | 4 days | Tang Kevin C and 2 others10% Owner | SSale | −838.7K | $7.75 | −$6.50M | −47.7%921.3K after | 10 lots |
ODT Odonate Therapeutics, Inc.
Chief Executive Officer1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 19, 2021 (view filing)4:38 PM ET | Nov 17-19 | 2 days | Tang Kevin C and 3 othersChief Executive Officer | SSale | −2.75M | $2.09 | −$5.73M | −17.7%12.8M after | 8 lots |